Author

P. Begin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Finzi· 3 shared G. Beaudoin-Bussieres· 3 shared R. Bazin· 3 shared A. Laumaea· 2 shared J. Prevost· 2 shared A. Lewin· 1 shared A. Tauzin· 1 shared C. Bourassa· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Finzi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice

I. Ullah, G. Beaudoin-Bussieres, K. Symmes, M. Cloutier, E. Ducas, A. Tauzin, A. Laumaea, P. Begin, W. Mothes, R. Bazin, A. Finzi, P. D. Uchil

This study shows that CCPs with high Fc-effector activity, rather than just neutralizing ability, are more effective in treating SARS-CoV-2 in mice.

bioRxiv · Jun 10, 2022Immunology

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

S. P. Anand, J. Prevost, M. Nayrac, G. Beaudoin-Bussieres, M. Benlarbi, R. Gasser, N. Brassard, A. Laumaea, S. Y. Gong, C. Bourassa, E. Brunet-Ratnasingham, H. Medjahed, G. Gendron-Lepage, G. Goyette, L. Gokool, , A. Finzi

This study tracks humoral immune responses in convalescent individuals up to 8 months post-SARS-CoV-2 infection, showing that IgG+ memory B cells persist while plasma antibody levels decline.

bioRxiv · Jan 25, 2021Microbiology

Longitudinal analysis of the humoral response to SARS-CoV-2 spike RBD in convalescent plasma donors

J. Perreault, T. Tremblay, M.-J. Fournier, M. Drouin, G. Beaudoin-Bussieres, J. Prevost, A. Lewin, P. Begin, A. Finzi, R. Bazin

The paper tracks antibody levels against SARS-CoV-2 RBD in convalescent plasma donors over time, finding a decline in antibodies after ~76 days post-symptoms onset.

bioRxiv · Jul 16, 2020 · PreprintImmunology